These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34927495)

  • 1. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
    Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
    J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
    Alegria W; Marini BL; Gregg KS; Bixby DL; Perissinotti A; Nagel J
    J Natl Compr Canc Netw; 2022 Feb; 20(3):245-252. PubMed ID: 35120305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
    Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
    J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
    Winget MD; Gatwood K; Jayani R; Biltibo E; Jallouk A; Jerkins J; Dholaria B; Kim TK; Savani B; Kassim A; McNeer E; Choi L; Orton L
    Transplant Cell Ther; 2024 Oct; 30(10):1031.e1-1031.e9. PubMed ID: 39074685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
    Nedved AN; DeFrates SR; Hladnik LM; Stockerl-Goldstein KE
    Pharmacotherapy; 2016 Oct; 36(10):1087-1094. PubMed ID: 27521990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
    Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
    J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
    [No Abstract]   [Full Text] [Related]  

  • 8. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
    Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
    Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
    Aguilar-Guisado M; Espigado I; Martín-Peña A; Gudiol C; Royo-Cebrecos C; Falantes J; Vázquez-López L; Montero MI; Rosso-Fernández C; de la Luz Martino M; Parody R; González-Campos J; Garzón-López S; Calderón-Cabrera C; Barba P; Rodríguez N; Rovira M; Montero-Mateos E; Carratalá J; Pérez-Simón JA; Cisneros JM
    Lancet Haematol; 2017 Dec; 4(12):e573-e583. PubMed ID: 29153975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.
    Gupta A; Singh M; Singh H; Kumar L; Sharma A; Bakhshi S; Raina V; Thulkar S
    Med Oncol; 2010 Dec; 27(4):1037-45. PubMed ID: 19830601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
    Lee P; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
    Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
    J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
    Snyder M; Pasikhova Y; Baluch A
    Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.
    Caro J; Madero-Marroquin R; Zubizarreta N; Moshier E; Tremblay D; Coltoff A; Lancman G; Fuller R; Rana M; Mascarenhas J; Jacobs SE
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):903-911. PubMed ID: 36109322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
    Rearigh L; Stohs E; Freifeld A; Zimmer A
    Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.
    Schmidt-Hieber M; Teschner D; Maschmeyer G; Schalk E
    Expert Rev Anti Infect Ther; 2019 Dec; 17(12):983-995. PubMed ID: 30686067
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
    Joudeh N; Sawafta E; Abu Taha A; Hamed Allah M; Amer R; Odeh RY; Salameh H; Sabateen A; Aiesh BM; Zyoud SH
    BMC Infect Dis; 2023 Feb; 23(1):106. PubMed ID: 36814229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An unusual cause of febrile neutropenia: brucellosis].
    Solmaz S; Asma S; Ozdoğu H; Yeral M; Turunç T
    Mikrobiyol Bul; 2014 Oct; 48(4):669-73. PubMed ID: 25492662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.
    Van de Wyngaert Z; Berthon C; Debarri H; Bories C; Bonnet S; Nudel M; Carpentier B; Legrand C; Barbieux S; Chauvet P; Simonnet A; Willaume A; Bossard JB; Renaud L; Wattebled KJ; Escure G; Branche N; Arib I; Titecat M; Quesnel B; Alfandari S
    Int J Antimicrob Agents; 2019 Jun; 53(6):781-788. PubMed ID: 30831232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
    Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.